Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

27.35

+0.02 (0.07%)

Jul 24, 2026, 4:00 PM EDT - Market closed

Arcutis Biotherapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	415.62	376.07	196.54	59.61	3.69	-
Revenue Growth	95.30%	91.34%	229.73%	1517.09%	-	-
Gross Profit	377.98	339.38	177.41	54.62	2.93	-
Operating Income	3.21	-12.23	-128.4	-241.1	-301.63	-206.53
Net Income	-2.38	-16.14	-140.04	-262.14	-311.46	-206.36
Earnings Per Share	-0.03	-0.13	-1.16	-3.78	-5.66	-4.18
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
ZORYVE Cream 0.3%	130.28	121	85.08	29.19	3.69
ZORYVE Foam	201.28	181.89	71.54	-	-
ZORYVE Cream 0.15%	79.8	68.27	9.92	-	-
ZORYVE Cream 0.05%	-	0.91	-	-	-
Other Segment	-	4	30	30.42	-
Revenue (Total)	415.62	376.07	196.54	59.61	3.69

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	224.31	221.29	228.57	272.79	410.82	388.6
Total Debt	114.67	114.23	109.77	205.92	202.54	77.56
Net Cash (Debt)	109.64	107.07	118.81	66.87	208.28	311.04
Net Cash Growth	24.72%	-9.88%	77.67%	-67.89%	-33.04%	10.68%
Net Cash Per Share	0.84	0.84	0.98	0.96	3.78	6.30

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	26.99	-5.63	-112.16	-247.06	-257.72	-174.63
Capital Expenditures	-0.08	-0.69	-0.14	-0.43	-0.33	-1
Free Cash Flow	26.92	-6.31	-112.3	-247.49	-258.05	-175.62
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.94%	90.24%	90.27%	91.63%	79.54%	-
Operating Margin	0.77%	-3.25%	-65.33%	-404.49%	-8183.04%	-
Pretax Margin	-0.33%	-3.98%	-70.92%	-434.57%	-8449.76%	-
Profit Margin	-0.57%	-4.29%	-71.25%	-439.79%	-8449.76%	-
FCF Margin	6.48%	-1.68%	-57.14%	-415.20%	-7000.76%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	87.30	76.62	-	-	-	-
PS Ratio	8.23	9.52	8.35	5.24	245.08	-